NCT05194475|Completed
Loading search results
Sponsor study identifier
interventional
28
1 country
1
Study Start
January 18, 2022
Actual (reported)Primary Completion
May 6, 2022
Actual (reported)Study Completion
May 6, 2022
Actual (reported)This study is a randomized, double-blind, placebo-controlled crossover trial examining the metabolic effects of a novel ready-to-drink (RTD) beverage. Healthy adult males and females will be recruited for participation. Each participant will complete two conditions in random order: 1) RTD thermogenic beverage ; and 2) placebo (consisting of the flavoring of the thermogenic beverage without the active ingredients). In each condition, metabolism (resting metabolic rate), hemodynamic (heart rate and blood pressure), and subjective (ratings of energy, focus, concentration, alertness, and mood) assessments will be completed at baseline, 30 minutes after beverage consumption, and 30 minutes after the second round of assessments.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 6, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 3, 2022
Actual (reported)January 18, 2022
Actual (reported)January 18, 2022
Actual (reported)May 6, 2022
Actual (reported)May 6, 2022
Actual (reported)Resting metabolic rate
Resting metabolic rate from indirect calorimetry expressed as kilocalories expended per unit time (e.g., kcal/min).
140 minutes
Respiratory quotient
Respiratory quotient from indirect calorimetry in arbitrary units, which reflects the proportion of carbohydrate and fat oxidized at rest.
140 minutes
Subjective rating of energy
140 minutes
Subjective rating of focus
140 minutes
Subjective rating of concentration
140 minutes
Subjective rating of alertness
140 minutes
Subjective rating of mood
140 minutes
Arm in which a thermogenic ready-to-drink beverage is ingested.
Arm in which a placebo ready-to-drink beverage is ingested.
Thermogenic ready-to-drink beverage, which will be ingested by the participant.
Placebo ready-to-drink beverage, which will be ingested by the participant.
Department of Kinesiology & Sport Management
Lubbock, Texas, 79409, United States
Grant M Tinsley, PhD
Texas Tech University
28 participants (actual enrollment reported by the registry).
First Submitted
January 3, 2022
First Posted
January 18, 2022
Study Start
January 18, 2022
Actual (reported)Impact of Probiotics on Drug, Vitamin, and Hormone Metabolism
Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
May 6, 2022
Actual (reported)Study Completion
May 6, 2022
Actual (reported)Last Updated
August 9, 2022
Record last verified: 2022-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: